Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease - PubMed (original) (raw)

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

S B Berman et al. J Neurochem. 1999 Sep.

Free article

Abstract

Both reactive dopamine metabolites and mitochondrial dysfunction have been implicated in the neurodegeneration of Parkinson's disease. Dopamine metabolites, dopamine quinone and reactive oxygen species, can directly alter protein function by oxidative modifications, and several mitochondrial proteins may be targets of this oxidative damage. In this study, we examined, using isolated brain mitochondria, whether dopamine oxidation products alter mitochondrial function. We found that exposure to dopamine quinone caused a large increase in mitochondrial resting state 4 respiration. This effect was prevented by GSH but not superoxide dismutase and catalase. In contrast, exposure to dopamine and monoamine oxidase-generated hydrogen peroxide resulted in a decrease in active state 3 respiration. This inhibition was prevented by both pargyline and catalase. We also examined the effects of dopamine oxidation products on the opening of the mitochondrial permeability transition pore, which has been implicated in neuronal cell death. Dopamine oxidation to dopamine quinone caused a significant increase in swelling of brain and liver mitochondria. This was inhibited by both the pore inhibitor cyclosporin A and GSH, suggesting that swelling was due to pore opening and related to dopamine quinone formation. In contrast, dopamine and endogenous monoamine oxidase had no effect on mitochondrial swelling. These findings suggest that mitochondrial dysfunction induced by products of dopamine oxidation may be involved in neurodegenerative conditions such as Parkinson's disease and methamphetamine-induced neurotoxicity.

PubMed Disclaimer

Cited by

Oxidative stress and Parkinson's disease.
Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Blesa J, et al. Front Neuroanat. 2015 Jul 8;9:91. doi: 10.3389/fnana.2015.00091. eCollection 2015. Front Neuroanat. 2015. PMID: 26217195 Free PMC article. Review.
Neurobehavioral alterations in a mouse model of chronic partial sleep deprivation.
Arora S, Dharavath RN, Bansal Y, Bishnoi M, Kondepudi KK, Chopra K. Arora S, et al. Metab Brain Dis. 2021 Aug;36(6):1315-1330. doi: 10.1007/s11011-021-00693-9. Epub 2021 Mar 19. Metab Brain Dis. 2021. PMID: 33740181
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.
Hauser DN, Hastings TG. Hauser DN, et al. Neurobiol Dis. 2013 Mar;51:35-42. doi: 10.1016/j.nbd.2012.10.011. Epub 2012 Oct 12. Neurobiol Dis. 2013. PMID: 23064436 Free PMC article. Review.
Ultrastructural localization of nitrotyrosine within the caudate-putamen nucleus and the globus pallidus of normal rat brain.
Bolan EA, Gracy KN, Chan J, Trifiletti RR, Pickel VM. Bolan EA, et al. J Neurosci. 2000 Jul 1;20(13):4798-808. doi: 10.1523/JNEUROSCI.20-13-04798.2000. J Neurosci. 2000. PMID: 10864937 Free PMC article.
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
Hastings TG. Hastings TG. J Bioenerg Biomembr. 2009 Dec;41(6):469-72. doi: 10.1007/s10863-009-9257-z. J Bioenerg Biomembr. 2009. PMID: 19967436

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease - PubMed (original) (raw)